Pfizer’s 2025 Outlook Aligns with Analyst Expectations, Driving Stock Up
Pfizer’s 2025 projections align with analyst expectations, signaling continued stability. The company anticipates steady revenue and increased EPS, driven by cost-cutting and returning growth.
Pfizer’s 2025 Outlook Aligns with Analyst Expectations, Driving Stock Up Read More »